- Home
- / Pyxis Oncology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Pyxis Oncology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.8
2024-10-29
Market Capitalization
$227 M
2024-10-29
Revenue
$13.9 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 16.1M | 13.9M | |||
| Cost of goods sold | 475.0K | 2.4M | |||
| Gross profit | 15.7M | 11.5M | |||
| Gross profit margin, % | 97.1% | 82.8% | |||
| General and administrative expense | 18.7M | 37.4M | 32.6M | 25.4M | 22.2M |
| Operating expense total | 123.5M | 105.1M | 95.9M | ||
| EBIT | (69.7M) | (123.5M) | (82.2M) | (89.5M) | (84.4M) |
| EBIT margin, % | -554.1% | -609.2% | |||
| Investment income | (231.0K) | 6.6M | 7.0M | 3.6M | |
| Interest income | 23.0K | 2.8M | 1.8M | 930.0K | |
| Interest expense | 10.0K | ||||
| Pre tax profit | (79.5M) | (78.2M) | |||
| Income tax expense | (2.2M) | 1.4M | |||
| Net Income | (76.0M) | (120.7M) | (73.8M) | (77.3M) | (79.6M) |
| EPS | (3.6) | (1.0) | (1.3) | (1.3) |